EXPE vs RAPT · P/E 20, rev $7.74B vs $132.1M cap
Expedia Group Inc. (EXPE) versus RAPT Therapeutics Inc (RAPT) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. RAPT currently screens at market cap $132.1M.
Not investment advice. Open the EXPE and RAPT stock pages for the full models.
Not investment advice.